Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phlebotonics for venous insufficiency.

M J Martinez1, X Bonfill, R M Moreno

  • 1Hospital de la Santa Creu i Sant Pau, Iberoamerican Cochrane Center, Service of Epidemiology, Sant Antoni M. Claret, 171, Barcelona, Spain, 08041. mmartinezz@hsp.santpau.es

The Cochrane Database of Systematic Reviews
|July 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing endometrial microbiota in endometriosis: culturomics and sequencing analysis of receptive-phase tissue.

Current research in microbial sciences·2026
Same author

Evidence gaps in orthognathic surgery: an international Delphi study.

International journal of oral and maxillofacial surgery·2024
Same author

Hospitalization determinants in patients with Mpox disease: The CEME-22 Project.

Heliyon·2024
Same author

Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study).

Open forum infectious diseases·2024
Same author

Sentinel Lymph Node Biopsy in Elderly Melanoma Patients: A Real Practice Cohort.

Actas dermo-sifiliograficas·2023
Same author

Systematic mapping review of interventions to prevent blood loss, infection and relapse in orthognathic surgery.

Medicina oral, patologia oral y cirugia bucal·2023
Same journal

Interventions to prevent or cease electronic cigarette use in children and adolescents.

The Cochrane database of systematic reviews·2026
Same journal

Drugs to improve anaemia, quality of life, and physical function in people with myelodysplastic syndromes (MDS).

The Cochrane database of systematic reviews·2026
Same journal

Interventions for smoking cessation in inpatient psychiatry settings.

The Cochrane database of systematic reviews·2026
Same journal

Mechanical thromboprophylaxis for preventing intradialytic hypotension in people undergoing maintenance haemodialysis.

The Cochrane database of systematic reviews·2026
Same journal

Prognostic models for predicting intensive care unit admission or mortality in critically ill adults not yet been admitted to the intensive care unit.

The Cochrane database of systematic reviews·2026
Same journal

Views and experiences of weight management for people living with mobility‑limiting conditions, intellectual disabilities or severe mental illness: a qualitative evidence synthesis.

The Cochrane database of systematic reviews·2026
See all related articles

Phlebotonics show some benefit for chronic venous insufficiency (CVI) symptoms like edema, but evidence is limited. More high-quality trials are needed to confirm their effectiveness for CVI treatment.

Area of Science:

  • Vascular Medicine
  • Pharmacology

Background:

  • Chronic venous insufficiency (CVI) affects leg vein blood flow, causing pain, swelling, and ulcers.
  • Phlebotonics are commonly prescribed for CVI management.

Purpose of the Study:

  • To evaluate the effectiveness of oral and topical phlebotonics for treating CVI.

Main Methods:

  • Systematic review of randomized, double-blind, placebo-controlled trials (RCTs).
  • Searched multiple databases (Cochrane, MEDLINE, EMBASE) and contacted pharmaceutical companies.
  • Included RCTs on various phlebotonics like rutosides, diosmine, and calcium dobesilate.

Main Results:

  • 44 RCTs with 4413 participants analyzed oral phlebotonics; no studies met criteria for topical agents.

Related Experiment Videos

  • Phlebotonics demonstrated a global benefit in reducing edema (RR 0.72).
  • Evidence for other CVI signs and symptoms was variable; no quality of life data were available.

    • Conclusions:

    • Insufficient evidence globally supports phlebotonic efficacy for CVI.
    • A potential benefit for edema reduction exists but has uncertain clinical relevance.
    • Further high-quality RCTs are necessary to establish efficacy and clinical utility.